Word

KISIMA

Status

Registered

Status Code

700

Status Date

Tuesday, October 9, 2018

Serial Number

87149001

Registration Number

5577986

Registration Date

Tuesday, October 9, 2018

Mark Type

4000

Filing Date

Wednesday, August 24, 2016

Published for Opposition

Tuesday, July 24, 2018

Trademark Owner History

AMAL Therapeutics SA - Original Registrant

Classifications

5 Pharmaceutical, medical and veterinary preparations, namely, proteins, peptides, and modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules, namely, peptides, proteins, nucleic acids and derivatives of peptides, proteins, and nucleic acids for medical and pharmaceutical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; diagnostic preparations for medical and veterinary use; biological preparations, namely, proteins, peptides, modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; cells for medical purposes; pharmaceutical preparations and compositions, namely, pharmaceutical preparations and compositions for the treatment and prevention of cancer; nucleic acids, in particular recombinant nucleic acids; nucleic acids for medical purposes, namely, for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; nucleic acid sequences for medical purposes, namely, for diagnostic purposes and the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins for medical purposes, namely, for diagnostic purposes and for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules and biologically active substances for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; kits containing preparations for medical purposes, comprised primarily of pharmaceutical preparations for the treatment and prevention of tumor and cancer diseases, and pharmaceutical preparations namely, proteins, peptides, modified peptides for the treatment and prevention of infectious diseases, and autoimmune diseases

1 Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins used in industry and science, in particular peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins for industrial and scientific purposes, all the foregoing being chemical preparations for industrial and scientific use; biochemical products, in the nature of biochemical preparations and substances for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes, namely, biochemical peptide substrates for laboratory or research use; proteins for use in science, industry and manufacture; biological preparations, namely, cell cultures, tissue cultures; chemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes and biochemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes; nucleic acids, in particular recombinant nucleic acids; nucleic acids for scientific purposes; nucleic acid sequences; biological active peptides for scientific and research purposes; antisera for scientific and industrial purposes; all above other than for medical and veterinary use

44 Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services, namely, pest control for agriculture, horticulture and forestry, farming services in the field of grain; Pharmaceutical services, namely, pharmaceutical advice, pharmaceutical compounding services; Medical information

42 Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and research services in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to science; medical product and pharmaceutical research and development services; biological scientific research and development and clinical scientific research and development services; research and development services all relating to industry in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical and pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical product and scientific research and development; medical and pharmaceutical product development and evaluation; Pharmaceutical, medical, biotechnological and biochemical research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries, namely, planning, design and management of information technology systems, consulting in the field of information technology, design and development of computer software

The English translation of "KISIMA" in the mark is "WATER WELL".

Trademark Events

Oct 9, 2023

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Oct 9, 2018

Registered-Principal Register

Jul 24, 2018

Official Gazette Publication Confirmation E-Mailed

Jul 24, 2018

Published For Opposition

Jul 4, 2018

Notification Of Notice Of Publication E-Mailed

Jun 20, 2018

Approved For Pub - Principal Register

Jun 18, 2018

Teas/Email Correspondence Entered

Jun 18, 2018

Correspondence Received In Law Office

Jun 11, 2018

Teas Response To Office Action Received

Jun 11, 2018

Teas Change Of Correspondence Received

Dec 20, 2017

Notification Of Non-Final Action E-Mailed

Dec 20, 2017

Non-Final Action E-Mailed

Dec 20, 2017

Non-Final Action Written

Nov 28, 2017

Teas/Email Correspondence Entered

Nov 28, 2017

Correspondence Received In Law Office

Nov 26, 2017

Teas Response To Suspension Inquiry Received

Jun 8, 2017

Notification Of Letter Of Suspension E-Mailed

Jun 8, 2017

Letter Of Suspension E-Mailed

Jun 8, 2017

Suspension Letter Written

May 16, 2017

Teas/Email Correspondence Entered

May 16, 2017

Correspondence Received In Law Office

May 12, 2017

Assigned To Lie

Apr 20, 2017

Teas Response To Office Action Received

Dec 7, 2016

Notification Of Non-Final Action E-Mailed

Dec 7, 2016

Non-Final Action E-Mailed

Dec 7, 2016

Non-Final Action Written

Dec 5, 2016

Assigned To Examiner

Aug 29, 2016

New Application Office Supplied Data Entered

Aug 27, 2016

New Application Entered